01713nas a2200193   4500008004100000022001400041245013600055210006900191260011000260300001600370490000600386520089000392100002601282700001701308700002701325700002101352700002501373856012101398       2014                        eng d  a2046-206900aFrom micron to nano-curcumin by sophorolipid co-processing: highly enhanced bioavailability, fluorescence, and anti-cancer efficacy0 aFrom micron to nanocurcumin by sophorolipid coprocessing highly   aTHOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLANDbROYAL SOC CHEMISTRYcNOV  a60334-603410 v43 a<p>Co-sonication of curcumin and acidic sophorolipid in aqueous solution is shown to lead to a dramatic enhancement of curcumin bioavailability through size reduction and encapsulation. The interaction between the two is studied and discussed based on optical absorption, photoluminescence, dynamic light scattering (DLS), zeta potential, FE-SEM, TEM, Infrared spectroscopy and X-ray diffraction measurements. The cytotoxicity effects of curcumin on breast cancer cell lines, MCF-7 and MDA-MB-231, are shown to be significantly enhanced by the formation of its complex with sophorolipid. The relative cytotoxicity of curcumin with its SL(A) complex is more due to the presence of the glucose moiety. The results further suggest that sophorolipid based formulations, which solubilize and nano-encapsulate curcumin after lipid digestion, show great potential for curcumin cell entry.</p>1 aSingh, Pradeep, Kumar1 aWani, Kirtee1 aKaul-Ghanekar, Ruchika1 aPrabhune, Asmita1 aOgale, Satishchandra  uhttps://library.ncl.res.in/content/micron-nano-curcumin-sophorolipid-co-processing-highly-enhanced-bioavailability-200829nas a2200181   4500008004100000022001400041245016000055210006900215260011000284300001000394490000600404100002600410700001700436700002700453700002100480700002500501856012100526       2015                        eng d  a2046-206900aFrom micron to nano-curcumin by sophorolipid co-processing: highly enhanced bioavailability, fluorescence, and anti-cancer efficacy (vol 4, pg 60334, 2014)0 aFrom micron to nanocurcumin by sophorolipid coprocessing highly   aTHOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLANDbROYAL SOC CHEMISTRYcFEB  a220750 v51 aSingh, Pradeep, Kumar1 aWani, Kirtee1 aKaul-Ghanekar, Ruchika1 aPrabhune, Asmita1 aOgale, Satishchandra  uhttps://library.ncl.res.in/content/micron-nano-curcumin-sophorolipid-co-processing-highly-enhanced-bioavailability-102599nas a2200193   4500008004100000245011600041210006900157260000800226300001200234490000800246520190600254100001702160700001702177700002102194700001702215700002402232700002702256856012202283       2016                        eng d00aEvaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula0 aEvaluating the anticancer activity and nanoparticulate nature of  cNOV  a318-3260 v1053 aBackground: Breast cancer is the most common cancer diagnosed among women and is the second leading cause of cancer death. Homeopathic medicines are part of the alternative medicines that are given as a supportive therapy in breast cancer. The objective of this study was to investigate the anticancer activity of commercially available homeopathic preparations of Terminalia chebula (TC) and evaluate their nanoparticulate nature. 
Methods: Mother tincture (MT) and other homeopathic preparations (3X, 6C and 30C) of TC were tested for their effect on the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell growth assay was performed to analyze the effect of the different potencies on the growth kinetics of breast cancer cells. MT and 6C were evaluated for the presence of nanoparticles by using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). 
Results: MT decreased the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cells. However, the other potencies (3X, 6C and 30C) decreased the viability of only breast cancer cells without affecting the viability of the non-cancerous cells. All the potencies, MT, 3X, 6C and 30C, reduced growth kinetics of breast cancer cells, more specifically at 1:10 dilution at 24, 48 and 72 h. Under SEM, MT appeared as a mesh-like structure whereas under TEM, it showed presence of nanoclusters. On the other hand, 6C potency contained 20 nm sized nanoparticles. 
Conclusion: The current study reports the anticancer activity of homeopathic preparations of TC against breast cancer and reveals their nanoparticulate nature. These preliminary results warrant further mechanistic studies at both in vitro and in vivo levels to evaluate the potential of TC as nanomedicine in breast cancer.1 aWani, Kirtee1 aShah, Nilesh1 aPrabhune, Asmita1 aJadhav, Arun1 aRanjekar, Prabhakar1 aKaul-Ghanekar, Ruchika  uhttps://library.ncl.res.in/content/evaluating-anticancer-activity-and-nanoparticulate-nature-homeopathic-preparations